Search research articles
Contact Us
Filters
Showing results (11-20 of 29) with videos related to
Page
of 3
Sort By:
The Journal of Biological Chemistry
|
September 12, 2008
Cyclin-dependent kinase 2 negatively regulates human pregnane X receptor-mediated CYP3A4 gene expression in HepG2 liver carcinoma cells
Wenwei Lin, Jing Wu, Hanqing Dong, et al.
Frontiers in Immunology
|
April 27, 2019
Poly-ICLC, a TLR3 Agonist, Induces Transient Innate Immune Responses in Patients With Treated HIV-Infection: A Randomized Double-Blinded Placebo Controlled Trial
Mansi Saxena, Rachel L Sabado, Melissa La Mar, et al.
Chemistry & Biology
|
June 9, 2015
Hijacking the E3 Ubiquitin Ligase Cereblon to Efficiently Target BRD4
Jing Lu, Yimin Qian, Martha Altieri, et al.
Cancer Research
|
September 4, 2012
ROCK1 and ROCK2 are required for non-small cell lung cancer anchorage-independent growth and invasion
Dominico Vigil, Tai Young Kim, Ana Plachco, et al.
Communications Biology
|
October 2, 2018
Androgen receptor degradation by the proteolysis-targeting chimera ARCC-4 outperforms enzalutamide in cellular models of prostate cancer drug resistance
Jemilat Salami, Shanique Alabi, Ryan R Willard, et al.
Cell Chemical Biology
|
November 14, 2017
The Advantages of Targeted Protein Degradation Over Inhibition: An RTK Case Study
George M Burslem, Blake E Smith, Ashton C Lai, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
June 9, 2016
PROTAC-induced BET protein degradation as a therapy for castration-resistant prostate cancer
Kanak Raina, Jing Lu, Yimin Qian, et al.
Journal of Medicinal Chemistry
|
July 11, 2017
Identification and Characterization of Von Hippel-Lindau-Recruiting Proteolysis Targeting Chimeras (PROTACs) of TANK-Binding Kinase 1
Andrew P Crew, Kanak Raina, Hanqing Dong, et al.
Bioorganic & Medicinal Chemistry Letters
|
February 17, 2005
Glucokinase-activating ureas
Arlindo L Castelhano, Hanqing Dong, Matthew C T Fyfe, et al.
Bioorganic & Medicinal Chemistry Letters
|
January 22, 2011
Potent and selective cyclohexyl-derived imidazopyrazine insulin-like growth factor 1 receptor inhibitors with in vivo efficacy
Meizhong Jin, Andrew Kleinberg, Andy Cooke, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 29) with videos related to
Sort By:
Page
of 3
The Journal of Biological Chemistry
|
September 12, 2008
Cyclin-dependent kinase 2 negatively regulates human pregnane X receptor-mediated CYP3A4 gene expression in HepG2 liver carcinoma cells
Wenwei Lin, Jing Wu, Hanqing Dong, et al.
Frontiers in Immunology
|
April 27, 2019
Poly-ICLC, a TLR3 Agonist, Induces Transient Innate Immune Responses in Patients With Treated HIV-Infection: A Randomized Double-Blinded Placebo Controlled Trial
Mansi Saxena, Rachel L Sabado, Melissa La Mar, et al.
Chemistry & Biology
|
June 9, 2015
Hijacking the E3 Ubiquitin Ligase Cereblon to Efficiently Target BRD4
Jing Lu, Yimin Qian, Martha Altieri, et al.
Cancer Research
|
September 4, 2012
ROCK1 and ROCK2 are required for non-small cell lung cancer anchorage-independent growth and invasion
Dominico Vigil, Tai Young Kim, Ana Plachco, et al.
Communications Biology
|
October 2, 2018
Androgen receptor degradation by the proteolysis-targeting chimera ARCC-4 outperforms enzalutamide in cellular models of prostate cancer drug resistance
Jemilat Salami, Shanique Alabi, Ryan R Willard, et al.
Cell Chemical Biology
|
November 14, 2017
The Advantages of Targeted Protein Degradation Over Inhibition: An RTK Case Study
George M Burslem, Blake E Smith, Ashton C Lai, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
June 9, 2016
PROTAC-induced BET protein degradation as a therapy for castration-resistant prostate cancer
Kanak Raina, Jing Lu, Yimin Qian, et al.
Journal of Medicinal Chemistry
|
July 11, 2017
Identification and Characterization of Von Hippel-Lindau-Recruiting Proteolysis Targeting Chimeras (PROTACs) of TANK-Binding Kinase 1
Andrew P Crew, Kanak Raina, Hanqing Dong, et al.
Bioorganic & Medicinal Chemistry Letters
|
February 17, 2005
Glucokinase-activating ureas
Arlindo L Castelhano, Hanqing Dong, Matthew C T Fyfe, et al.
Bioorganic & Medicinal Chemistry Letters
|
January 22, 2011
Potent and selective cyclohexyl-derived imidazopyrazine insulin-like growth factor 1 receptor inhibitors with in vivo efficacy
Meizhong Jin, Andrew Kleinberg, Andy Cooke, et al.
Page
of 3